Regarding the pivotal role of the TGF-β1/SMAD3 signaling pathway in activated HSCs, it seems that inhibition of this pathway could be beneficial in treatment of liver fibrosis. The gene discussed is TGFB1; the disease is Hepatic fibrosis.